What's less comprehended is why drug manufacturers spend billions for re-search on uses for their services and products - when the drug was submitted for approval uses which were never cleared using the FDA. Off-label use allows drug organizations to get 'through the rear door' what they might never, and I am talking about never, break free with by going directly to the FDA for approval for a new use of a product - what's known today being an off-label use. Going To Xarelto Lawsuit Says Manufacturers Fraudulently Misrepresented The Drug probably provides suggestions you should give to your aunt. You'd hope that researchers wouldn't corrupt the professional testing of-a new, or off-label, use of a drug to treat kids by covering up their consulting charges from Big Pharma. But that is what happened. Harvard Drug Study Fraud and Cover-up: How Off-Label Profiteering Works Medicine business money corrupts and influences re-search. That's a given. What's less understood is why drug manufacturers spend millions for research o-n off-label uses for their products and services - uses which were never cleared with the FDA if the drug was submitted for approval. Off-label use allows drug organizations to have 'through the back door' what they may never, and I am talking about never, get away with by going straight to the FDA for approval for a new use of a product - what is known today being an off-label use. To read additional info, you may have a gander at: Xarelto Lawsuit Says Manufacturers Fraudulently Misrepresented The Drug. You would hope that researchers wouldn't corrupt the industrial testing of the new, or off-label, use of a drug to deal with kids by covering up their consulting costs from Big Pharma. But that's what happened. More crucial than what happened is excatly why it happened and at the bottom of this can be a bad mistake the U.S. has produced in allowing the exploitation of off-label use. The devil is in the facts, so here is the story since it has unfolded. To compare additional information, you might claim to check out: Xarelto Lawsuit Says Manufacturers Fraudulently Misrepresented The Drug. Leading Harvard professors learning off-label uses, the gold-mine of the drug industry, have broken National Institute of Health r-eporting requirements when over $10,000 continues to be received from the subject company, according to the New York Times, 'Researchers Fail to Reveal Drug Pay' June 8, 2008. http://www.nytimes.com/2008/06/08/us/08conflict.html?em&ex=1213070400&en=9971013dfd33290a&ei=508720say20are%20sorry&st=cse isn't enough. If Harvard does not fire them, it will be complicit in the cover-up. Throw them off campus. Ring the bell loud and clear that regardless of how renown or exceptional, if you do not play by the principles, you can not play at all. And THEY should be forever banned by the NIH from receiving grants. Visit Xarelto Lawsuit Says Manufacturers Fraudulently Misrepresented The Drug to explore why to think over this idea. Don't throw out the baby with the bath water. Once correct consequence is served, give these researchers a chance to shine their damaged reputations. Permit them to conduct research under the direction of a responsible manager who understands that 'veritas,' means truth, reliability, honesty, and uprightness and that it is more than merely a motto. Forward. Richard Alexander http://www.alexanderinjury.com.